As shown in Figure 1, compared with normal tissues, GOT2 expression was higher in BLCA (Bladder Urothelial Carcinoma), CESC (Cervical squamous cell carcinoma and endocervical adenocarcinoma), COAD (Colon adenocarcinoma), KICH (Kidney Chromophobe), ESCA (Esophageal carcinoma), LUAD (Lung adenocarcinoma), LUSC (Lung squamous cell carcinoma), STAD (Stomach adenocarcinoma) and UCEC (Uterine Corpus Endometrial Carcinoma). This evidence concerns the gene GOT2 and colon adenocarcinoma.